Form 8-K - Current report:
SEC Accession No. 0001193125-20-165709
Filing Date
2020-06-10
Accepted
2020-06-10 16:20:02
Documents
2
Period of Report
2020-06-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942891d8k.htm 8-K 28536
2 EX-3.1 d942891dex31.htm EX-3.1 3112
  Complete submission text file 0001193125-20-165709.txt   32885
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 20954906
SIC: 2834 Pharmaceutical Preparations